These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 12688637)

  • 41. GTP-binding protein-independent potentiation by mastoparan of IL-1beta-induced nitric oxide release from insulin-secreting HIT-T15 cells.
    Chen HQ; Veluthakal R; Palanivel R; Kowluru A
    Apoptosis; 2004 Mar; 9(2):145-8. PubMed ID: 15004511
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IL-1beta-induced iNOS expression, NO release and loss in metabolic cell viability are resistant to inhibitors of ceramide synthase and sphingomyelinase in INS 832/13 cells.
    Veluthakal R; Jangati GR; Kowluru A
    JOP; 2006 Nov; 7(6):593-601. PubMed ID: 17095838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. STAT5 activation by human GH protects insulin-producing cells against interleukin-1beta, interferon-gamma and tumour necrosis factor-alpha-induced apoptosis independent of nitric oxide production.
    Jensen J; Galsgaard ED; Karlsen AE; Lee YC; Nielsen JH
    J Endocrinol; 2005 Oct; 187(1):25-36. PubMed ID: 16214938
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ceramide induces mitochondrial abnormalities in insulin-secreting INS-1 cells: potential mechanisms underlying ceramide-mediated metabolic dysfunction of the beta cell.
    Veluthakal R; Palanivel R; Zhao Y; McDonald P; Gruber S; Kowluru A
    Apoptosis; 2005 Aug; 10(4):841-50. PubMed ID: 16133874
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of Rho-associated kinase in differential regulation by statins of interleukin-1beta- and lipopolysaccharide-mediated nuclear factor kappaB activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells.
    Wei CY; Huang KC; Chou YH; Hsieh PF; Lin KH; Lin WW
    Mol Pharmacol; 2006 Mar; 69(3):960-7. PubMed ID: 16317111
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IL-1beta-induced nitric oxide release from insulin-secreting beta-cells: further evidence for the involvement of GTP-binding proteins.
    Tannous M; Veluthakal R; Amin R; Kowluru A
    Diabetes Metab; 2002 Dec; 28(6 Pt 2):3S78-84; discussion 3S108-12. PubMed ID: 12688637
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibitors of post-translational modifications of G-proteins as probes to study the pancreatic beta cell function: potential therapeutic implications.
    Kowluru A; Amin R
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Jul; 2(2):129-39. PubMed ID: 12476787
    [TBL] [Abstract][Full Text] [Related]  

  • 48. GTP-binding proteins in cell survival and demise: the emerging picture in the pancreatic beta-cell.
    Kowluru A; Morgan NG
    Biochem Pharmacol; 2002 Mar; 63(6):1027-35. PubMed ID: 11931834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Covalent modification of G proteins by affinity labeling.
    Hohenegger M; Freissmuth M; Nanoff C
    Methods Mol Biol; 1997; 83():179-90. PubMed ID: 9210145
    [No Abstract]   [Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.